Lamivudine therapy of chronic hepatitis B.
Hunt
C M
CM
Department of Infectious Diseases, Glaxo Wellcome Incorporated, Research Triangle Park, North Carolina 27709, USA.
Brown
N A
NA
Rubin
M
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*
D000998:Antiviral Agents; D019259:Lamivudine